Antiprotozoal Aminosteroids from Pachysandra terminalis
Molecules · 27.02.2025 · 30 (5) · 1093
DOI: 10.3390/molecules30051093 ↗Kurz gefasst
Fachartikel in der Zeitschrift Molecules, online erschienen am 27.02.2025. Verfasst von Lizanne Schäfer und 4 weiteren Autor:innen. Beteiligte Einrichtung: University of Münster, Institute of Pharmaceutical Biology and Phytochemistry (IPBP), PharmaCampus Corrensstraße 48, D-48149 Münster, Germany. Hauptthemen laut MEDLINE: Antiprotozoal Agents, Buxaceae. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 52 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Apothekerstiftung Westfalen-Lippe.
Abstract (Originalsprache)
Trypanosoma brucei rhodesiense (Tbr) and Plasmodium falciparum (Pf) are protozoan parasites that cause severe diseases, namely, Human African Trypanosomiasis (HAT) and Malaria. Due to limited treatment options, there is an urgent need for new antiprotozoal drugs. Pachysandra terminalis (P. terminalis), a plant belonging to the family Buxaceae, is known as a rich source of aminosteroid alkaloids, and a previous study of our working group already showed that the alkaloid-enriched fraction of P. terminalis aerial parts showed promising activity against protozoan parasites. In the present study, the alkaloid-enriched fraction obtained from a 75% ethanol extract of aerial parts was separated to isolate a chemically diverse array of Pachysandra alkaloids for assessment of their antiprotozoal activity and later structure–activity studies. This work yielded a new megastigmane alkaloid (1), 7 new aminosteroids (2, 7, 16, 17, 18, 19, 20), along with 10 known aminosteroids (3–5, 8, 10–15) and 2 artifacts (6, 9) that were formed during the isolation process. The structures were elucidated by UHPLC/+ESI-QqTOF-MS/MS, as well as extensive 1- and 2D-NMR measurements. The extract and its fractions, as well as the isolated compounds, were tested in vitro against Tbr and Pf, as well as cytotoxicity against mammalian cells (L6 cell line). The activity (IC50 values) of the isolated alkaloids ranged between 0.11 and 26 µM (Tbr) and 0.39 and 80 µM (Pf). 3α,4α-diapachysanaximine A (7) showed the highest activity against Tbr (IC50 = 0.11 µM) with a selectivity index (SI) of 133 and was also quite active against Pf with IC50 = 0.63 µM (SI = 23). This compound is, therefore, a promising new antiprotozoal target for further investigations.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- University of Münster, Institute of Pharmaceutical Biology and Phytochemistry (IPBP), PharmaCampus Corrensstraße 48, D-48149 Münster, Germany.
- Swiss Tropical and Public Health Institute (Swiss TPH), Kreuzstrasse 2, CH-4123 Allschwil, Switzerland.
- University of Basel, Petersplatz 1, CH-4003 Basel, Switzerland.
ORCID-Profile: Marcel Kaiser, Pascal Mäser, Thomas J Schmidt
Förderung
- Apothekerstiftung Westfalen-Lippe
Zitieren
APA
Schäfer, L., Cal, M., Kaiser, M., Mäser, P., & Schmidt, T. J. (2025). Antiprotozoal Aminosteroids from Pachysandra terminalis. Molecules, 30(5), 1093. https://doi.org/10.3390/molecules30051093
Vancouver
Schäfer L, Cal M, Kaiser M, Mäser P, Schmidt TJ. Antiprotozoal Aminosteroids from Pachysandra terminalis. Molecules. 2025;30(5):1093. doi:10.3390/molecules30051093
BibTeX
@article{Schfer2025,
author = {Schäfer, Lizanne and Cal, Monica and Kaiser, Marcel and Mäser, Pascal and Schmidt, Thomas J},
title = {Antiprotozoal Aminosteroids from Pachysandra terminalis},
journal = {Molecules},
year = {2025},
volume = {30},
number = {5},
pages = {1093},
doi = {10.3390/molecules30051093}
}
EUVIMED